DR. DARREN WOOD -- PATHOBIOLOGY Donations to Pet Trust are helping OVC researchers working to develop a simple, non-invasive blood test that may predict how canine lymphoma patients will respond to th
DR. ALEX VALVERDE -- CLINICAL STUDIES OVC researchers are investigating whether a common antihistamine used to treat allergies and other conditions is also helpful when given to dogs undergoing mast c
INVESTIGATING THE FEASIBILITY OF IMMUNOTHERAPY IN TREATING DOGS WITH MELANOMA DR. BYRAM BRIDLE -- PATHOBIOLOGY Pet Trust is supporting research that aims to fight cancer in dogs by directing their own
OBTAINING CLINICAL SAMPLES OF CANINE MELANOMA FOR DEVELOPMENT OF MOUSE XENOGRAFTS Principal Investigator Jennifer Luff Description Melanomas in both humans and dogs are a common and highly aggressive
Ingredients 1 pound ground beef or ground chicken (or a combination of ground meats) 3.25 ounces organic puffed rice 3.25 ounces large flake oats or oatmeal 1.25 ounces wheat germ 1 egg, with shell 1
Cancer is diagnosed in many different ways, but there are common threads among many different cancers. Sometimes a pet develops an abnormal lump or bump. Sometimes there is a behaviour change . . . d
Suzi receives the prestigious Queen Elizabeth II Diamond Jubilee Medal.
Comet has been doing very well and is currently off all medications related to his transplant. He has no signs of graft versus host disease, is apparently free of lymphoma, and has sustained engraftm
February 13th, 2017 MINNEAPOLIS/ST.PAUL — A breakthrough trial at the University of Minnesota testing a new UMN-developed drug resulted in improved survival rates for dogs diagnosed with a canc
Bone cancer similar to the one that killed Terry Fox spreads fast in dogs and humans alike. A clinical trial on in Guelph, Ontario, could hold the key for treating it in both species. This post
Study Name: Osteosarcoma and Meloxicam Study Purpose of the study: The purpose of this study is to evaluate the benefits of the drug meloxicam inthe postoperative pain management of canine patients
Dr. Jaime Modiano is the lab principal investigator. He hails from Mexico City, where he graduated from the baccalaureate program at Colegio Columbia. He did undergraduate work in Biomedical Sciences